Inovio Wins $80.42 Million Judgment Against VGXI, GeneOne

Bitget2026/10/20 20:08

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Inovio Pharmaceuticals won an $80.42 million judgment against VGXI and GeneOne Life Science in Pennsylvania's Montgomery County Court of Common Pleas.
The award includes $61.75 million in compensatory damages and $18.67 million in fees and costs; the court also rejected defendants' counterclaims.
The lawsuit, filed June 3, 2020, concerned defendants' breach of technology transfer obligations under a supply agreement for DNA plasmid manufacturing.
Defendants' financial condition will likely impair collection of some or all of the judgment; Inovio intends to pursue recovery.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610201605PR_NEWS_USPR_____PH76932) on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Inovio Wins $80.42 Million Judgment Against VGXI, GeneOne

You may also like

Crypto prices